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Abstract
Conclusion. Cell transplantation into the utriculus provides an efficient and non-invasive route to introduce embryonic stem
(ES) cells into the vestibular and cochlear portions of the inner ear. Objective. The transfer of stem cells into the inner ear for
therapeutic purposes is an important approach to cure damage to the cochlea and vestibulum. A key issue is to provide an
entry point for cell transplants into the inner ear that does not affect its physiologic functions. The aim of this study was to
examine the feasibility of transferring ES cells into the inner ear via the utriculus. Materials and methods. ES cells were
injected via utriculostomy into the mouse inner ear. The distribution of the injected cells was determined using a beta-
galactosidase marker gene expressed by the ES cells. Results. Injected ES cells were found within the perilymph of the scala
tympani and vestibuli. Moreover, ES cells were detected close to the cochlear sensory epithelium and spiral limbus.
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Introduction
Diseases of the inner ear such as presbycusis,
tinnitus, sudden hearing loss or vertigo affect mil-
lions of people worldwide. To date, there are only
symptomatic treatments of empiric pharmacology or
technical devices for hearing loss. There is no
specific cure and in the case of vertigo there is
no cure at all. The advent of stem cells has raised
some hope for these patients. With their potential to
differentiate into virtually any cell type, it might be
possible to replace sensory or neuronal cells within
the inner ear, thereby restoring the inner ear function
of hearing and balance [1,2].
Next to the question as to whether stem cells of
embryonic or adult origin will be able to fulfill the
physiologic functions of endogenous inner ear cells,
a key issue is to resolve how to transfer cells inside
the inner ear. In this context transfer into the cochlea
is especially difficult due to its complex and fragile
structure composed of liquid-filled spaces sur-
rounded by membranes and encased within the
temporal bone [2]. Access routes to the cochlea
have classically comprised drilling a hole into the
cochlea via cochleostomy, providing access to the
scala tympani or even directly to the scala media,
thus providing a direct entry point for cells to reach
the organ of Corti. Alternatively, cells may be
transplanted without cochleostomy via a less invasive
route by injecting them through the round window
[3,4]. Another route with no damage to the mem-
branes that seal the endolymphatic and perilympha-
tic spaces is provided by injection into the internal
auditory meatus [5]. However, in all cases these
manipulations are associated with localized surgical
trauma to the cochlea and carry the risk of inflam-
mation and sensorineural hearing loss [2,6,7]. Thus,
an approach that avoids direct physical contact with
the cochlea may provide a more safe and reliable
route to transfer cells into the cochlea. We have
recently defined a non-invasive route for gene
transfer into the cochlea that uses the utriculus as
an entry point into the inner ear [8]. Here, we have
tested the feasibility of using this protocol to
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introduce embryonic stem (ES) cells into the co-
chlea. Our results demonstrate that ES cells intro-
duced via the utriculus efficiently reach the cochlea
and are found next to potential targets for cell
therapy. This protocol may thus be further devel-
oped as a non-invasive route for ES cell-based
therapies within the cochlea.
Materials and methods
Animals and anesthesia
All studies used adult C57BL/6 mice and were
approved by the University of Homburg/Saar guide-
lines for animal care and housing. Anesthesia for
surgery and hearing measurements was induced
using a mixture of fentanyl (0.05 mg/kg; Janssen
Cilag, Germany), midazolam (2 mg/kg; Hoffmann-
La-Roche, Germany), and medetomidine (0.15 mg/
kg; SmithKline Beecham, Finland).
Stem cell culture
ES cells that carry a beta-galactosidase gene inte-
grated at the ROSA26 locus [9] were cultured under
routine conditions [10]. ES cells were maintained on
10 mm tissue culture dishes containing a mitomycin
C-treated mouse embryonic fibroblast layer. ES cells
were washed three times in PBS, 5 ml 0.25%
trypsin-EDTA were added, and cells were incubated
at 378C for 5 min. Cells were then gently pipetted to
obtain a single-cell suspension, centrifuged at 700 g
for 5 min, and finally resuspended in ES cell
medium and distributed onto fresh culture dishes.
ES cell medium consisted of DMEM with Gluta-
max-I, supplemented with 15% ES-tested FBS, 1%
NEAA, 1% penicillin-streptomycin, 10 mM Hepes,
0.1 mM 2-mercaptoethanol, and 1000 U/ml LIF.
Surgical procedure
The procedure was carried out as described else-
where [8]. Briefly, after induction of anesthesia, a
dorsal post-auricular approach allowed exposure of
the facial nerve, the posterior semicircular canal, and
the bulla. A diamond drill was used to open the
bulla. After identification of the stapes, the stapedial
artery, and the round window niche (Figure 1), the
bone covering the utriculus was determined just
below the stapedial artery dorsal to the basal
cochlear turn and round window membrane niche.
Inferior to the stapedial artery just below the entry of
the middle ear cavity, an utriculostomy was per-
formed using a 0.5 mm diamond drill. Then 4 ml of
the suspended stem cells were slowly applied
through the utriculostomy using a 10 ml Hamilton
syringe with a 28 gauge blunt needle (n5) followed
by a small patch of connective tissue that was
subsequently placed onto the opening. Application
of 4 ml of 0.9% NaCl solution and connective tissue
at the utriculostomy in two mice served as controls.
Immunohistochemistry and histology
At 4 days after the application procedure, animals
were euthanized by intracardiac perfusion with 2%
PBS-buffered paraformaldehyde. The cochleae and
brains were removed and post-fixed for 2 h in 2%
paraformaldehyde, 125 mM sucrose, and 100 mM
PBS (pH7.4) at 48C. The cochleae were decalci-
fied in Calex (Fisher Diagnostics, USA) for 2 h at
room temperature. All samples were embedded in
paraffin, sectioned in 6 mm slices, deparaffinized,
stained with hematoxylin and eosin (H&E), sealed
with vectastain and a coverslip, and evaluated
microscopically. To detect the expression of the
lacZ gene expressed by the stem cell line, immunos-
taining with an antibody against beta-galactosidase
(Sigma) and a secondary antibody labelled with
rhodamine was performed.
Results
Transfer of ES cells into the inner ear via utriculostomy
Following the injection of ES cells via the utriculus
(see Materials and methods) cochleae were exam-
ined for the distribution of ES cells in the cochlea
after 4 days. Sections stained with H&E revealed a
high amount of injected ES cells within the scala
tympani and vestibuli at all levels along the basal
apical axis of the cochlea (Figure 2 and data not
shown).
Localization of ES cells within the cochlea
To further identify and localize the injected ES cells
within the cochlea we stained sections with an
antibody directed against beta-galactosidase that
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Figure 1. Isolated inner ear indicating the stapedial artery sulcus
and the round window membrane. The oval window and the entry
site for a cochleostomy are also indicated.
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specifically detects ES cells since they carry a beta-
galactosidase gene integrated within their genome
[9]. Inspection of sections under the immunofluor-
escence microscope revealed the presence of ES cells
expressing beta-galactosidase (Figure 3). Aggregates
or clumps of cells could be detected in the scala
tympani underneath the organ of Corti (Figure 3A)
and attached to the spiral limbus (Figure 3B).
Discussion
The introduction of stem cells into the cochlea to
replace lost or damaged sensory cells or neurons is
an attractive objective. However, several hurdles
have to be overcome to guarantee a reliable and
safe protocol for cell transfer to the target areas.
Firstly, the introduction of the cells should be
minimally invasive to the cochlear structures. Many
protocols have relied on cochleostomy or injection
through the round window membrane, which carries
several risks for damage to the cochlea and conse-
quently hearing loss [2,6,7]. The vestibular route is
thus an attractive alternative that leaves the sensitive
cochlear structures untouched. Our results demon-
strate that injection of ES cells into the utriculus
leads to an efficient transfer of ES cells to the scala
tympani and scala vestibuli. Injected cells reach the
scalae via the radial and longitudinal circulation of
perilymph and apparently travel via the helicotrema
from the scala vestibuli to the scala tympani.
Importantly, injected ES cells are found close to
the eventual targets of cellular therapy, e.g. the organ
of Corti or the cochlear ganglion and its nerve fibers
within the spiral limbus.
Alternative entry points for cell transfer in the
vestibular system are the semicircular canals [11,12].
Comparative studies have confirmed that transfer of
stem cells or viral vectors to the cochlea via
canalostomy preserves cochlear function whereas
cochleostomy leads to hearing loss [11,13]. Our
recent studies have demonstrated that gene transfer
into the utriculus did not affect auditory brainstem
responses (ABRs) of the operated animals [8].
However, the high amount of ES cells present in
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Figure 2. Presence of embryonic stem cells in the cochlea after cellular transfer into the utriculus. (A) Section through the apical part of the
cochlea. Note the presence of embryonic stem cells in the scala vestibuli (SV) and scala tympani (ST), but not in the scala media (SM). (B)
Magnification of the boxed area indicated in (A). OC, organ of Corti. Scale bar corresponds to 200 mm.
Figure 3. Detection of embryonic stem cells (SC) in the cochlea. Antibodies raised against beta-galactosidase detect SC in the scala
tympani (ST) underneath the organ of Corti (OC) in (A). In (B) SC (marked by arrows) are found attached to the spiral limbus (SL). Scale
bar corresponds to 50 mm in (A) and 75 mm in (B).
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the scala tympani in the present study will affect the
normal physiology of the cochlea. Therefore, the
amount of injected ES cells will have to be reduced
or their distribution throughout the cochlea im-
proved. On the other hand, operated animals that
received ES cells (this study) or viral vectors [8] by
utriculostomy showed no behavioral abnormalities,
indicating that no vestibular defects had been
caused. Finally, we found no indications for an
inflammatory response. Therefore, although the
technique described here needs further refinement
the utriculus appears to represent an attractive entry
point for cell-based therapies.
An apparent drawback of the vestibular approach
is that cells within the scala tympani or scala vestibuli
would still have to reach their final destinations
within the cochlear sensory epithelium or the
cochlear ganglion. However, several studies have
now provided evidence that stem cells are able to
reach Rosenthal’s canal and the scala media, most
likely by their migration from the scala tympani
through the caniculae perforantes of Schuhknecht
[3,5,14,15]. Moreover, different types of injected
stem cells, including ES cells, have been shown to
express neuronal or hair cell markers and to integrate
within the relevant target areas for cellular therapy
[14,1619]. Interestingly, stem cells within the
perilymphatic space have also been shown to ame-
liorate hearing impairment observed 4 days after
transient cochlear ischemia without transdifferentia-
tion into cochlear cell types [20]. Continued re-
search on the safe transfer of stem cells to the
cochlea and stem cell differentiation within the inner
ear may thus provide important insights for future
stem cell-based therapies.
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